Rs 65 Million Investment Sparks Interest in Renewable Energy Acquisition by Subsidiary of Biocon Rs 65 Million Investment Sparks Interest in Renewable Energy Acquisition by Subsidiary of Biocon Syngene International Limited has a market capitalization of over Rs 28,000 crore, a 1-year return of 3 per cent, a 3-year return of 25 per cent and a PE ratio of 60. DSIJ Intelligence-1 / Tuesday, March 25, 2025 / Article rating: 4.3 Syngene International Limited has a market capitalization of over Rs 28,000 crore, a 1-year return of 3 per cent, a 3-year return of 25 per cent and a PE ratio of 60.
Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter With a PE ratio of 57.6x, the company trades at a premium compared to the industry PE of 46x. The company has ROCE of 14.7 per cent and ROE of 13.2 per cent. DSIJ Intelligence-2 / Tuesday, March 11, 2025 / Article rating: 5.0
Rs 465 Crore Bet on the Future: Big Pharma’s Massive US Expansion in the Works! Rs 465 Crore Bet on the Future: Big Pharma’s Massive US Expansion in the Works! Strategic investment to strengthen global presence and enhance biologics manufacturing capabilities. DSIJ Intelligence / Tuesday, March 11, 2025 / Article rating: 4.5 Strategic investment to strengthen global presence and enhance biologics manufacturing capabilities.